Breaking News Instant updates and real-time market news.

AYI

Acuity Brands

$242.99

-12.01 (-4.71%)

08:42
10/06/16
10/06
08:42
10/06/16
08:42

Acuity Brands weakness a buying opportunity, says Baird

Baird analyst Timothy Wojs said the weakness in Acuity Brands is a buying opportunity as the risk/reward is now skewed to the upside following its pullback. The analyst noted its quarterly miss was due to temporary manufacturing issues and his long term thesis remains unchanged. Wojs reiterated his Outperform rating and $272 price target on Acuity Brands shares.

  • 12

    Oct

  • 06

    Jan

AYI Acuity Brands
$242.99

-12.01 (-4.71%)

10/05/16
WBLR
10/05/16
NO CHANGE
WBLR
Acuity Brands weakness a buying opportunity, says William Blair
10/05/16
ROTH
10/05/16
NO CHANGE
Target $250
ROTH
Neutral
Acuity Brands price target lowered to $250 from $275 at Roth Capital
Roth Capital analyst Craig Irwin lowered his price target for Acuity Brands to $250 from $275 after the company posted Q4 "disappointing" results, delivering revenue and adjusted EPS below his estimates. The analyst says the company stated revenue was impacted by $25M due to a labor shortage as it took actions to streamline its supply chain, and notes Acuity Brands' commentary for fiscal 2017 remains optimistic. He reiterates a Neutral rating on the shares.
10/06/16
ADAM
10/06/16
NO CHANGE
Target $286
ADAM
Buy
Acuity Brands weakness a buying opportunity, says Canaccord
Canaccord analyst John Quealy said the earnings miss at Acuity Brands was due to a rare operational stumble in a still vibrant market for LED and energy efficiency technologies. As a result, Quealy recommends buying the shares on weakness as the company continues to set the pace for aggressive growth and platform expansion across the marketplace. Quealy reiterated his Buy rating and lowered his price target to $286 form $305 on Acuity Brands shares.
10/06/16
COWN
10/06/16
NO CHANGE
Target $285
COWN
Outperform
Acuity Brands growth story remains intact, says Cowen
Cowen analyst Jeffrey Osborne noted Acuity Brands' quarterly results missed on both earnings and revenues, which was primarily due to a labor shortage caused by a shift in production facilities. Management believes it was a short-term issue and unlikely to impact Q1 results, Osborne said. The analyst believes the growth story remains intact and would use the share weakness as a buying opportunity. Osborne reiterated his Outperform rating and $285 price target on Acuity Brands shares.

TODAY'S FREE FLY STORIES

TREX

Trex Company

$69.81

-0.76 (-1.08%)

07:03
02/21/17
02/21
07:03
02/21/17
07:03
Earnings
Trex Company reports Q4 EPS 43c, consensus 41c »

Reports Q4 revenue $95M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

XCRA

Xcerra

$8.30

0.13 (1.59%)

07:02
02/21/17
02/21
07:02
02/21/17
07:02
Earnings
Xcerra reports Q2 non-GAAP EPS 6c, consensus (2c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$61.65

-0.14 (-0.23%)

07:01
02/21/17
02/21
07:01
02/21/17
07:01
Hot Stocks
Six Flags signs agreement to build Six Flags-branded parks at second China site »

Six Flags Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

INOV

Inovalon

$11.30

-0.45 (-3.83%)

07:01
02/21/17
02/21
07:01
02/21/17
07:01
Recommendations
Inovalon analyst commentary  »

Piper sees lawsuit as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SRPT

Sarepta

$28.28

0.31 (1.11%)

07:00
02/21/17
02/21
07:00
02/21/17
07:00
Hot Stocks
Sarepta agrees to sale of priority review voucher for $125M »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

SEAS

SeaWorld

$19.21

-0.03 (-0.16%)

07:00
02/21/17
02/21
07:00
02/21/17
07:00
Earnings
Breaking Earnings news story on SeaWorld »

SeaWorld reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TVPT

Travelport

$14.14

-0.06 (-0.42%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Travelport reports Q4 adjusted EPS 23c, consensus 20c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

MDT

Medtronic

$78.88

0.89 (1.14%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Medtronic reports Q3 EPS $1.12, consensus $1.11 »

Reports Q3 revenue $7.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

REXR

Rexford Industrial

$22.92

0.24 (1.06%)

06:57
02/21/17
02/21
06:57
02/21/17
06:57
Hot Stocks
Rexford Industrial acquires industrial property in Los Angeles for $17.1M »

Rexford Industrial Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$41.74

0.36 (0.87%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Hot Stocks
Loxo Oncology completes enrollment for larotrectinib NDA »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$30.37

-0.08 (-0.26%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Periodicals
GE succession plan near top of investors' minds, WSJ says »

General Electric CEO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Apr

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVN

Trevena

$7.13

0.1 (1.42%)

06:55
02/21/17
02/21
06:55
02/21/17
06:55
Hot Stocks
Breaking Hot Stocks news story on Trevena »

Trevena trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 21

    Mar

TIF

Tiffany

$86.18

3.17 (3.82%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Tiffany, JANA Partners announce agreement to appoint 3 new independent directors »

Tiffany and JANA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Breaking Hot Stocks news story on Enable Midstream »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:53
02/21/17
02/21
06:53
02/21/17
06:53
Earnings
Enable Midstream reports Q4 EPS 14c, consensus 18c »

Reports Q4 revenue $614M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WLK

Westlake Chemical

$61.66

-0.99 (-1.58%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Earnings
Westlake Chemical reports Q4 EPS 76c with items, consensus 80c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JNCE

Jounce Therapeutics

$19.90

0.24 (1.22%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Initiation
Jounce Therapeutics initiated  »

Jounce Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

06:50
02/21/17
02/21
06:50
02/21/17
06:50
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDR

EdR

$40.69

-0.06 (-0.15%)

06:48
02/21/17
02/21
06:48
02/21/17
06:48
Earnings
EdR reaffirms FY17 EPS view 66c-76c, consensus 63c »

Sees FY17 core FFO per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HURN

Huron

$42.60

-4 (-8.58%)

06:48
02/21/17
02/21
06:48
02/21/17
06:48
Downgrade
Huron rating change  »

Huron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

EDR

EdR

$40.69

-0.06 (-0.15%)

06:47
02/21/17
02/21
06:47
02/21/17
06:47
Earnings
EdR reports Q4 EPS 19c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MCO

Moody's

$112.90

2.68 (2.43%)

06:45
02/21/17
02/21
06:45
02/21/17
06:45
Downgrade
Moody's rating change  »

Moody's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 02

    Mar

  • 05

    Mar

RIC

Richmont Mines

$9.30

-0.2 (-2.11%)

06:45
02/21/17
02/21
06:45
02/21/17
06:45
Earnings
Richmont Mines reports Q4 EPS 1c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LMOS

Lumos Networks

$15.23

0.09 (0.59%)

, ZAYO

Zayo Group

$30.83

-0.16 (-0.52%)

06:41
02/21/17
02/21
06:41
02/21/17
06:41
Downgrade
Lumos Networks, Zayo Group, GTT Communications rating change  »

Lumos Networks downgraded…

LMOS

Lumos Networks

$15.23

0.09 (0.59%)

ZAYO

Zayo Group

$30.83

-0.16 (-0.52%)

GTT

GTT Communications

$29.00

-0.05 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.